Prasugrel
Prasugrel (CS-747) is a thienopyridine-class antiplatelet agent used to inhibit thrombosis in acute coronary syndromes and during percutaneous coronary intervention. Its active metabolite irreversibly antagonizes the P2Y12 ADP receptor, a mechanism validated in both in vitro platelet aggregation assays and in vivo preclinical models of arterial thrombosis.
Product Specifications
CAS Number
150322-43-3
Product Name Alternative
P2YReceptor, P2Y12, P2Y Receptor, P2Y, Prasugrel, platelet, CS 747, CS747, CS-747, antiplatelet, aggregation, ADP, active, inhibit, Inhibitor, LY 640315, LY640315, LY-640315, metabolite, PCR 4099, PCR4099, PCR-4099
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.62% (May vary between batches)
Solubility
DMSO:45 mg/mL (120.5 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.36 mM)
Smiles
C (C (=O) C1CC1) (N2CC3=C (CC2) SC (OC (C) =O) =C3) C4=C (F) C=CC=C4
Molecular Formula
C20H20FNO3S
Molecular Weight
373.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
042400-ML490 100 µL
Stk24, ID (Stk24, Mst3, Stk3, Serine/threonine-protein kinase 24, Mammalian STE20-like protein kinase 3, STE20-like kinase MST3, Serine/threonine-protein kinase 24 35kD subunit, Mammalian STE20-like protein kinase 3 N-terminal, Serine/threonine-protein kinase 24 12kD subunit, Mammalian STE20-like protein kinase 3 C-terminal) (MaxLight 490) discontinued
Sign In for Pricing
View Details